content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <!-- Generated by Workiva -->
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001720685</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001831828</issuerCik>
        <issuerName>Vera Therapeutics, Inc.</issuerName>
        <secFileNumber>001-40407</secFileNumber>
        <issuerAddress>
          <com:street1>8000 Marina Boulevard, Suite 120</com:street1>
          <com:city>Brisbane</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94005</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>650-770-0077</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Katabi Maha</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Director</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>J.P. Morgan Securities LLC</name>
          <address>
            <com:street1>390 Madison Avenue - 6th Floor</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10017</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>850000</noOfUnitsSold>
        <aggregateMarketValue>38530500</aggregateMarketValue>
        <noOfUnitsOutstanding>44432945</noOfUnitsOutstanding>
        <approxSaleDate>03/21/2024</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>10/29/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Pre-IPO shares converted to public equity at IPO</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>850000</amountOfSecuritiesAcquired>
        <paymentDate>10/29/2020</paymentDate>
        <natureOfPayment>Pre-IPO shares converted to public equity at IPO</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>The shares filed today will be sold by Sofinnova Venture Partners X, L.P., Katabi Maha as General Partner</remarks>
      <noticeSignature>
        <noticeDate>03/21/2024</noticeDate>
        <signature>/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Katabi Maha</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3036}]
text: 144
  0001720685
  XXXXXXXX
  LIVE
  0001831828
  Vera Therapeutics, Inc.
  001-40407
  8000 Marina Boulevard, Suite 120
  Brisbane
  CA
  94005
  650-770-0077
  Katabi Maha
  Director
  Common Stock
  J.P. Morgan Securities LLC
  390 Madison Avenue - 6th Floor
  New York
  NY
  10017
  850000
  38530500
  44432945
  03/21/2024
  NASDAQ
  Common Stock
  10/29/2020
  Pre-IPO shares converted to public equity at IPO
  Issuer
  N
  850000
  10/29/2020
  Pre-IPO shares converted to public equity at IPO
  Y
  The shares filed today will be sold by Sofinnova Venture Partners X, L.P., Katabi Maha as General Partner
  03/21/2024
  /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Katabi Maha